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Tuesday, February 28, 2012 533aKIS (KChIP4aD2-34) demonstrated that KChIP4a with KIS domain had no sig-
nificant effect on steady-state activation, but shifted the voltage dependence of
steady-state inactivation of Kv4.3 to hyperpolarizing direction by enhancing
closed-state inactivation. We have previously demonstrated that KChIP4a
can rescue the function of a tetramerization-defect mutant Kv4.3 C110A.
The rescued Kv4.3 C110A current is larger than that of WT Kv4.3/KChIP4a
co-expression, although C110A surface expression was lower. Upon coexpres-
sion, the closed-state inactivation of Kv4.3 C110A mutant was less affected by
the KIS domain, as compared with enhanced closed-state inactivation observed
in wild-type channel, suggesting a role of T1 domain in mediation of Kv4
closed-state inactivation. Taken together, we propose that N-terminal KIS do-
main of KChIP4a inhibits Kv4.3 function through dual independent mecha-
nisms by which auxiliary KChIP4a causes Kv4 ER retention and promotes
channel closed-state inactivation.
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Polyunsaturated fatty acids such as arachidonic acid (AA) demonstrate in-
hibitory modulation of Kv4 potassium channels. Molecular docking ap-
proaches using a new Kv4.2 homology model predicted a membrane-
embedded binding pocket for AA comprised of the S4-S5 linker on one
subunit and several nearby hydrophobic residues within the internal side
of S5 and S6 from an adjacent subunit. We tested the hypothesis that mod-
ulatory effects of AA on Kv4.2/KChIP channels require access to this site.
Targeted mutation of a lysine residue and a nonpolar residue within the S4-
S5 linker as well as a nonpolar residue in S3 significantly impaired the ef-
fects of AA on Kþ currents in Xenopus oocytes. These residues may be
important in stabilizing or regulating access to the negatively charged car-
boxylate moiety on the fatty acid. The structural specificity of this interac-
tion was supported by the lack of disruption of AA effects observed with
charge neutralizing mutations at residues located near but not within the
predicted binding pocket. Furthermore, we found that the crystal structure
of the Kv1.2/2.1 channel chimera lacks an AA docking site with the struc-
tural features present in the proposed hydrophobic pocket of Kv4.2 and the
chimera was likewise unaffected by AA. We simulated the mutagenic sub-
stitutions of critical residues identified in our Kv4.2 model to provide
a structural interpretation of the disruption of the AA binding pocket.
We conclude that AA inhibits Kv4 channel currents and facilitates inacti-
vation by interacting with a hydrophobic binding pocket in which a lysine
residue within the S4-S5 linker is important for AA interaction.
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NS5806 (N-[3,5-bis(trifluoromethyl)phenyl]-N-[2,4-dibromo-6-(1H-tetrazol-
5-yl)phenyl]-urea) can increase the amplitude and slow the decay of cur-
rents mediated by voltage-gated potassium (Kv) channels of the Kv4 sub-
family if Kv Channel Interacting Proteins (KChIPs) participate in channel
complex formation. We studied the effects of NS5806 on the somatoden-
dritic A-type current (Isa) in hippocampal neurons and on the currents me-
diated by Kv4.2 channels coexpressed with different auxilliary beta-subunits
in HEK 293 cells with the whole-cell patch-clamp technique. The effects of
NS5806 on the inactivation gating of Kv4.2 mutants were studied under
two-electrode voltage-clamp in Xenopus oocytes. Notably, the Isa compo-
nent in hippocampal neurons was reduced rather than potentiated, but
showed a pronounced slowing of inactivation in the presence of NS5806.
The peak amplitudes of currents mediated by ternary Kv4.2 channels, coex-
pressed with different KChIPs and dipeptidyl aminopeptidase-related pro-
tein (DPP) 6 were potentiated and their macroscopic inactivation slowed
by NS5806. The currents mediated by binary Kv4.2 channels, coexpressed
only with DPP6, were suppressed by NS5806 and the effects on macro-
scopic inactivation were less pronounced. Similar to the Isa component
in hippocampal neurons, the midpoint voltage of inactivation of recombi-
nant Kv4.2 channel complexes was shifted negative by NS5806. However,
the recovery from inactivation was accelerated in hippocampal neurons and
slowed in recombinant channels. Functional analysis of Kv4.2 S4S5 linker
and S6 mutants support the notion that NS5806 influences the dynamic
coupling between voltage sensor and gate.
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Inhibition of presynaptic voltage-gated potassium (Kv) channels by guanidine
underlies its use in the therapy for the neuromuscular diseases, myasthenic
syndrome of Lambert-Eaton and botulism. The therapeutic use of guanidine
is limited, however, due to side effects that accompany its administration.
Therefore, the design of guanidine analogs with improved therapeutic indices
is desirable. Progress towards this goal is hindered by the lack of knowledge
of the mechanism by which these molecules inhibit Kv channels. We examined
an array of possible mechanisms of inhibition of the Shaker Kv channel by gua-
nidine, methyl guanidine and N,N-dimethyl guanidine, including charge
screening, disruption of the protein-lipid interfaces, direct interaction with
the voltage sensors and pore-binding. Our results demonstrate that guanidines
bind within the intracellular pore of the channel, and perturb a hydrophobic
subunit interface to stabilize a closed state of the channel. This mechanism pro-
vides a foundation for the design of guanidine analogs for the therapeutic
intervention of neuromuscular diseases.
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General anesthetics have been shown to both inhibit and potentiate various
families of ion channels. However, the molecular bases of these actions are
not understood. Previous work with K-Shaw2 explored structural determinants
of inhibition by alkanols and the volatile general anesthetics halothane and iso-
flurane (Barber et al. Biophys J. 2011, in press). In this study, we report that
sevoflurane, an inhaled anesthetic currently used in human general anesthesia,
exhibits the singular ability to reversibly potentiate K-Shaw2 currents investi-
gated in Xenopus oocytes under two-electrode voltage-clamp conditions
(~80% potentiation at 1 mM). This result is in sharp contrast to the action of
multiple other inhaled (halothane, isoflurane, desflurane, chloroform, and 1-al-
kanols) and injected (propofol) general anesthetics, which are inhibitory. This
potentiation occurs over a clinically relevant concentration range (0.05 - 1 mM)
in a dose-dependent manner that suggests two binding sites with distinct
apparent affinities: a high-affinity site (K1 = 60 mM) and a low affinity site
(K2 = 4 mM). Furthermore, a double mutation involving the S6 segment and
the S4-S5 linker (A326V/A417V) abolishes the potentiation by sevoflurane.
This effect is especially interesting because this double mutation also abolishes
the inhibitory action of halothane, suggesting that these inhaled anesthetics
share effector sites but influence gating in opposite ways. Semiquantitative
kinetic modeling suggests that preferential binding of sevoflurane to resting
and activated closed states shifts the channels into a novel gating mode with
an enhanced open probability. Additional screening of related voltage-gated
K channels at a various doses of sevoflurane revealed only modest potentiation
of Kv1.2 no effect on Kv1.3, Kv2.1, Kv3.4 and Kv4.2. This study provides
a novel framework for further investigations of the structural basis of general
anesthetic action.
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The state of the art method to study ion channels is the patch clamp technology.
Since 2003, patch clamp automats offered an efficiently faster analysis method,
as it would have been feasible with the manual patch clamp technique. Never-
theless, the advantage of higher throughput in patch clamp automation is ac-
companied with a lower data quality.
The CytoPatchTM Instrument is a patch clamp automat with a new chip technol-
ogy, theCytocentering Technology.With this, the automat is capable to generate
a data quality and flexibility comparable to the manual patch clamp technology.
To investigate this issue we carried out a comparative study on the activation
and inactivation kinetics of the potassium channels KV1.3 and KV1.5 measured
on the CytoPatchTM Instrument and the manual patch clamp. The data prove
that advanced electrophysiological studies can be carried out on the Cyto-
PatchTM Instrument with similar results to the manual patch clamp technique.
Furthermore, it goes along with the benefit of automation which is: a higher
standardisation - walk away times of several hours - automated data evaluation -
no need of a highly-skilled person to run the instrument - higher throughput and
lower costs per data point.
